Tag: Amid biotech

Manufacturing, Research and Development

Amid biotech downturn, Atlas raises $450M to build new drug startups

March 3, 2022

Via: Biopharma Dive

Atlas is closing this fund amid one of the most severe biotech downturns in years, a retrenchment that’s constrained the options of private drug companies seeking to make the jump to public markets. Few biotechs are now pricing initial public […]